nodes	percent_of_prediction	percent_of_DWPC	metapath
Alprazolam—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.0922	0.182	CbGbCtD
Alprazolam—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.0922	0.182	CbGbCtD
Alprazolam—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0708	0.14	CbGbCtD
Alprazolam—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.0699	0.138	CbGbCtD
Alprazolam—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0478	0.0946	CbGbCtD
Alprazolam—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0456	0.0902	CbGbCtD
Alprazolam—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0406	0.0804	CbGbCtD
Alprazolam—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0239	0.0472	CbGbCtD
Alprazolam—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0225	0.0445	CbGbCtD
Alprazolam—CYP2C9—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—chronic obstructive pulmonary disease	0.00125	0.0143	CbGpPWpGaD
Alprazolam—GABRG2—Ion channel transport—ATP2C2—chronic obstructive pulmonary disease	0.00124	0.0142	CbGpPWpGaD
Alprazolam—CYP2C9—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A2—chronic obstructive pulmonary disease	0.00122	0.014	CbGpPWpGaD
Alprazolam—GABRB2—Ion channel transport—TRPV4—chronic obstructive pulmonary disease	0.00121	0.0138	CbGpPWpGaD
Alprazolam—GABRA5—Ion channel transport—TRPV4—chronic obstructive pulmonary disease	0.00118	0.0134	CbGpPWpGaD
Alprazolam—GABRA3—Ion channel transport—TRPV4—chronic obstructive pulmonary disease	0.00115	0.0132	CbGpPWpGaD
Alprazolam—GABRA2—Ion channel transport—TRPV4—chronic obstructive pulmonary disease	0.00113	0.013	CbGpPWpGaD
Alprazolam—GABRB3—Ion channel transport—TRPV4—chronic obstructive pulmonary disease	0.00113	0.0129	CbGpPWpGaD
Alprazolam—GABRG2—Ion channel transport—TRPV4—chronic obstructive pulmonary disease	0.00111	0.0127	CbGpPWpGaD
Alprazolam—GABRA1—Ion channel transport—ATP2C2—chronic obstructive pulmonary disease	0.00109	0.0124	CbGpPWpGaD
Alprazolam—CYP3A4—Aflatoxin B1 metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000988	0.0113	CbGpPWpGaD
Alprazolam—CYP2C9—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—chronic obstructive pulmonary disease	0.000978	0.0112	CbGpPWpGaD
Alprazolam—GABRA1—Ion channel transport—TRPV4—chronic obstructive pulmonary disease	0.000968	0.0111	CbGpPWpGaD
Alprazolam—CYP3A5—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	0.000956	0.0109	CbGpPWpGaD
Alprazolam—CYP3A7—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000922	0.0105	CbGpPWpGaD
Alprazolam—CYP3A5—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000917	0.0105	CbGpPWpGaD
Alprazolam—CYP2C9—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—chronic obstructive pulmonary disease	0.00089	0.0102	CbGpPWpGaD
Alprazolam—CYP3A5—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000882	0.0101	CbGpPWpGaD
Alprazolam—CYP3A4—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	0.000757	0.00865	CbGpPWpGaD
Alprazolam—CYP3A5—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000667	0.00762	CbGpPWpGaD
Alprazolam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.000664	0.00759	CbGpPWpGaD
Alprazolam—CYP2C9—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000647	0.00739	CbGpPWpGaD
Alprazolam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.000645	0.00738	CbGpPWpGaD
Alprazolam—CYP3A5—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000641	0.00733	CbGpPWpGaD
Alprazolam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.000634	0.00724	CbGpPWpGaD
Alprazolam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.000623	0.00712	CbGpPWpGaD
Alprazolam—CYP2C9—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000622	0.00711	CbGpPWpGaD
Alprazolam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.000619	0.00707	CbGpPWpGaD
Alprazolam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.000608	0.00694	CbGpPWpGaD
Alprazolam—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000587	0.00671	CbGpPWpGaD
Alprazolam—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.00055	0.00136	CcSEcCtD
Alprazolam—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.00055	0.00136	CcSEcCtD
Alprazolam—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.00055	0.00136	CcSEcCtD
Alprazolam—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000549	0.00136	CcSEcCtD
Alprazolam—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000549	0.00136	CcSEcCtD
Alprazolam—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000549	0.00136	CcSEcCtD
Alprazolam—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000548	0.00135	CcSEcCtD
Alprazolam—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000548	0.00135	CcSEcCtD
Alprazolam—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000545	0.00135	CcSEcCtD
Alprazolam—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000545	0.00135	CcSEcCtD
Alprazolam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.000541	0.00619	CbGpPWpGaD
Alprazolam—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000541	0.00134	CcSEcCtD
Alprazolam—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.00054	0.00134	CcSEcCtD
Alprazolam—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.00054	0.00134	CcSEcCtD
Alprazolam—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.00054	0.00133	CcSEcCtD
Alprazolam—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.00054	0.00133	CcSEcCtD
Alprazolam—CYP3A7—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000539	0.00616	CbGpPWpGaD
Alprazolam—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000538	0.00133	CcSEcCtD
Alprazolam—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.000538	0.00133	CcSEcCtD
Alprazolam—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000537	0.00133	CcSEcCtD
Alprazolam—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000536	0.00132	CcSEcCtD
Alprazolam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.000531	0.00607	CbGpPWpGaD
Alprazolam—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000529	0.00131	CcSEcCtD
Alprazolam—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000529	0.00131	CcSEcCtD
Alprazolam—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000527	0.00602	CbGpPWpGaD
Alprazolam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.000526	0.00601	CbGpPWpGaD
Alprazolam—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000525	0.0013	CcSEcCtD
Alprazolam—Infection—Formoterol—chronic obstructive pulmonary disease	0.000525	0.0013	CcSEcCtD
Alprazolam—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000521	0.00129	CcSEcCtD
Alprazolam—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000521	0.00129	CcSEcCtD
Alprazolam—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000521	0.00129	CcSEcCtD
Alprazolam—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000521	0.00129	CcSEcCtD
Alprazolam—CYP3A7—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.00052	0.00594	CbGpPWpGaD
Alprazolam—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000519	0.00128	CcSEcCtD
Alprazolam—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000519	0.00128	CcSEcCtD
Alprazolam—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000519	0.00128	CcSEcCtD
Alprazolam—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000518	0.00128	CcSEcCtD
Alprazolam—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000518	0.00128	CcSEcCtD
Alprazolam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.000517	0.0059	CbGpPWpGaD
Alprazolam—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000516	0.00128	CcSEcCtD
Alprazolam—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000516	0.00128	CcSEcCtD
Alprazolam—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000515	0.00127	CcSEcCtD
Alprazolam—Infection—Montelukast—chronic obstructive pulmonary disease	0.000515	0.00127	CcSEcCtD
Alprazolam—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	0.000514	0.00127	CcSEcCtD
Alprazolam—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000514	0.00127	CcSEcCtD
Alprazolam—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000514	0.00127	CcSEcCtD
Alprazolam—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000512	0.00127	CcSEcCtD
Alprazolam—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.00051	0.00583	CbGpPWpGaD
Alprazolam—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000509	0.00126	CcSEcCtD
Alprazolam—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000508	0.00126	CcSEcCtD
Alprazolam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.000508	0.0058	CbGpPWpGaD
Alprazolam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.000504	0.00576	CbGpPWpGaD
Alprazolam—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000503	0.00124	CcSEcCtD
Alprazolam—Euphoric mood—Prednisone—chronic obstructive pulmonary disease	0.000501	0.00124	CcSEcCtD
Alprazolam—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000499	0.00123	CcSEcCtD
Alprazolam—GABRB2—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000499	0.00571	CbGpPWpGaD
Alprazolam—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000496	0.00123	CcSEcCtD
Alprazolam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.000495	0.00566	CbGpPWpGaD
Alprazolam—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000494	0.00122	CcSEcCtD
Alprazolam—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000494	0.00122	CcSEcCtD
Alprazolam—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000492	0.00121	CcSEcCtD
Alprazolam—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000491	0.00121	CcSEcCtD
Alprazolam—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.000491	0.00121	CcSEcCtD
Alprazolam—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.00049	0.00121	CcSEcCtD
Alprazolam—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000487	0.0012	CcSEcCtD
Alprazolam—GABRA5—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000485	0.00554	CbGpPWpGaD
Alprazolam—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000485	0.0012	CcSEcCtD
Alprazolam—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000483	0.00119	CcSEcCtD
Alprazolam—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000483	0.00119	CcSEcCtD
Alprazolam—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000482	0.00119	CcSEcCtD
Alprazolam—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000482	0.00119	CcSEcCtD
Alprazolam—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000478	0.00118	CcSEcCtD
Alprazolam—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000478	0.00118	CcSEcCtD
Alprazolam—GABRA3—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000476	0.00544	CbGpPWpGaD
Alprazolam—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000476	0.00118	CcSEcCtD
Alprazolam—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000475	0.00117	CcSEcCtD
Alprazolam—GABRB2—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000473	0.0054	CbGpPWpGaD
Alprazolam—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000472	0.00117	CcSEcCtD
Alprazolam—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000471	0.00117	CcSEcCtD
Alprazolam—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000471	0.00117	CcSEcCtD
Alprazolam—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.00047	0.00116	CcSEcCtD
Alprazolam—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.00047	0.00116	CcSEcCtD
Alprazolam—CYP2C9—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.00047	0.00537	CbGpPWpGaD
Alprazolam—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000469	0.00116	CcSEcCtD
Alprazolam—GABRA2—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000468	0.00535	CbGpPWpGaD
Alprazolam—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000467	0.00115	CcSEcCtD
Alprazolam—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000466	0.00115	CcSEcCtD
Alprazolam—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000466	0.00115	CcSEcCtD
Alprazolam—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000465	0.00115	CcSEcCtD
Alprazolam—GABRB3—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000465	0.00532	CbGpPWpGaD
Alprazolam—CYP3A4—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000464	0.0053	CbGpPWpGaD
Alprazolam—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000464	0.00115	CcSEcCtD
Alprazolam—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000461	0.00114	CcSEcCtD
Alprazolam—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00046	0.00114	CcSEcCtD
Alprazolam—GABRA5—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000459	0.00525	CbGpPWpGaD
Alprazolam—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000458	0.00113	CcSEcCtD
Alprazolam—GABRG2—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000457	0.00522	CbGpPWpGaD
Alprazolam—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000457	0.00113	CcSEcCtD
Alprazolam—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000457	0.00113	CcSEcCtD
Alprazolam—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000456	0.00113	CcSEcCtD
Alprazolam—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000456	0.00113	CcSEcCtD
Alprazolam—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000456	0.00113	CcSEcCtD
Alprazolam—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000455	0.00112	CcSEcCtD
Alprazolam—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000452	0.00112	CcSEcCtD
Alprazolam—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000452	0.00112	CcSEcCtD
Alprazolam—CYP2C9—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000452	0.00516	CbGpPWpGaD
Alprazolam—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000452	0.00112	CcSEcCtD
Alprazolam—GABRA3—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000451	0.00515	CbGpPWpGaD
Alprazolam—Increased appetite—Prednisone—chronic obstructive pulmonary disease	0.000451	0.00111	CcSEcCtD
Alprazolam—Amnesia—Prednisone—chronic obstructive pulmonary disease	0.000451	0.00111	CcSEcCtD
Alprazolam—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000448	0.00111	CcSEcCtD
Alprazolam—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000447	0.00111	CcSEcCtD
Alprazolam—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000447	0.0011	CcSEcCtD
Alprazolam—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000445	0.0011	CcSEcCtD
Alprazolam—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	0.000444	0.00508	CbGpPWpGaD
Alprazolam—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000444	0.0011	CcSEcCtD
Alprazolam—GABRA2—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000443	0.00506	CbGpPWpGaD
Alprazolam—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000442	0.00109	CcSEcCtD
Alprazolam—GABRB3—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.00044	0.00503	CbGpPWpGaD
Alprazolam—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.00044	0.00109	CcSEcCtD
Alprazolam—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000438	0.00108	CcSEcCtD
Alprazolam—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000438	0.00108	CcSEcCtD
Alprazolam—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000436	0.00108	CcSEcCtD
Alprazolam—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000436	0.00108	CcSEcCtD
Alprazolam—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000435	0.00108	CcSEcCtD
Alprazolam—Flunitrazepam—CYP1A2—chronic obstructive pulmonary disease	0.000435	0.197	CrCbGaD
Alprazolam—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000434	0.00107	CcSEcCtD
Alprazolam—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000433	0.00107	CcSEcCtD
Alprazolam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.000433	0.00495	CbGpPWpGaD
Alprazolam—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000432	0.00107	CcSEcCtD
Alprazolam—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000432	0.00107	CcSEcCtD
Alprazolam—GABRG2—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000432	0.00494	CbGpPWpGaD
Alprazolam—Lethargy—Prednisone—chronic obstructive pulmonary disease	0.000432	0.00107	CcSEcCtD
Alprazolam—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000431	0.00107	CcSEcCtD
Alprazolam—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000431	0.00106	CcSEcCtD
Alprazolam—CYP3A7—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000427	0.00488	CbGpPWpGaD
Alprazolam—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000427	0.00106	CcSEcCtD
Alprazolam—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000426	0.00487	CbGpPWpGaD
Alprazolam—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000424	0.00105	CcSEcCtD
Alprazolam—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	0.000423	0.00105	CcSEcCtD
Alprazolam—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000423	0.00483	CbGpPWpGaD
Alprazolam—GABRB2—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000421	0.00481	CbGpPWpGaD
Alprazolam—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.00042	0.00104	CcSEcCtD
Alprazolam—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.00042	0.00104	CcSEcCtD
Alprazolam—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000418	0.00103	CcSEcCtD
Alprazolam—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000418	0.00103	CcSEcCtD
Alprazolam—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000418	0.00103	CcSEcCtD
Alprazolam—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000418	0.00103	CcSEcCtD
Alprazolam—Affect lability—Prednisone—chronic obstructive pulmonary disease	0.000417	0.00103	CcSEcCtD
Alprazolam—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000417	0.00103	CcSEcCtD
Alprazolam—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000413	0.00102	CcSEcCtD
Alprazolam—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000413	0.00102	CcSEcCtD
Alprazolam—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000413	0.00102	CcSEcCtD
Alprazolam—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000412	0.00102	CcSEcCtD
Alprazolam—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000412	0.00102	CcSEcCtD
Alprazolam—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000411	0.00101	CcSEcCtD
Alprazolam—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00041	0.00469	CbGpPWpGaD
Alprazolam—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000409	0.00101	CcSEcCtD
Alprazolam—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000409	0.00101	CcSEcCtD
Alprazolam—GABRA5—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000409	0.00468	CbGpPWpGaD
Alprazolam—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000408	0.00101	CcSEcCtD
Alprazolam—GABRB2—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000407	0.00465	CbGpPWpGaD
Alprazolam—Irritability—Prednisone—chronic obstructive pulmonary disease	0.000404	0.000999	CcSEcCtD
Alprazolam—GABRA3—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000402	0.00459	CbGpPWpGaD
Alprazolam—Mood swings—Prednisone—chronic obstructive pulmonary disease	0.000401	0.000991	CcSEcCtD
Alprazolam—GABRA1—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000399	0.00456	CbGpPWpGaD
Alprazolam—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000397	0.00098	CcSEcCtD
Alprazolam—GABRA5—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000395	0.00452	CbGpPWpGaD
Alprazolam—GABRA2—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000395	0.00451	CbGpPWpGaD
Alprazolam—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000395	0.000975	CcSEcCtD
Alprazolam—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000395	0.000975	CcSEcCtD
Alprazolam—GABRB3—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000392	0.00448	CbGpPWpGaD
Alprazolam—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.00039	0.000963	CcSEcCtD
Alprazolam—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.00039	0.000963	CcSEcCtD
Alprazolam—CYP3A5—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.00039	0.00445	CbGpPWpGaD
Alprazolam—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000389	0.000962	CcSEcCtD
Alprazolam—GABRA3—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000388	0.00444	CbGpPWpGaD
Alprazolam—Ketazolam—ALB—chronic obstructive pulmonary disease	0.000388	0.176	CrCbGaD
Alprazolam—GABRG2—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000385	0.0044	CbGpPWpGaD
Alprazolam—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000383	0.00438	CbGpPWpGaD
Alprazolam—GABRB2—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000383	0.00437	CbGpPWpGaD
Alprazolam—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000382	0.000943	CcSEcCtD
Alprazolam—GABRA2—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000382	0.00436	CbGpPWpGaD
Alprazolam—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000381	0.00435	CbGpPWpGaD
Alprazolam—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000379	0.000938	CcSEcCtD
Alprazolam—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000379	0.000938	CcSEcCtD
Alprazolam—GABRB3—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000379	0.00433	CbGpPWpGaD
Alprazolam—CYP3A7—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000378	0.00432	CbGpPWpGaD
Alprazolam—GABRA1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000378	0.00432	CbGpPWpGaD
Alprazolam—CYP3A5—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000376	0.0043	CbGpPWpGaD
Alprazolam—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000374	0.000925	CcSEcCtD
Alprazolam—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000374	0.000925	CcSEcCtD
Alprazolam—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.000373	0.000923	CcSEcCtD
Alprazolam—GABRG2—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000372	0.00426	CbGpPWpGaD
Alprazolam—GABRA5—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000372	0.00425	CbGpPWpGaD
Alprazolam—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000372	0.000918	CcSEcCtD
Alprazolam—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.00037	0.00423	CbGpPWpGaD
Alprazolam—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000368	0.000909	CcSEcCtD
Alprazolam—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000366	0.000906	CcSEcCtD
Alprazolam—GABRA3—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000365	0.00417	CbGpPWpGaD
Alprazolam—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000362	0.000894	CcSEcCtD
Alprazolam—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000362	0.000894	CcSEcCtD
Alprazolam—GABRA2—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000359	0.0041	CbGpPWpGaD
Alprazolam—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000358	0.000885	CcSEcCtD
Alprazolam—Loxapine—SLC6A4—chronic obstructive pulmonary disease	0.000358	0.162	CrCbGaD
Alprazolam—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.000357	0.000881	CcSEcCtD
Alprazolam—GABRB3—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000356	0.00407	CbGpPWpGaD
Alprazolam—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000356	0.00406	CbGpPWpGaD
Alprazolam—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000354	0.000876	CcSEcCtD
Alprazolam—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000353	0.000873	CcSEcCtD
Alprazolam—GABRG2—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.00035	0.004	CbGpPWpGaD
Alprazolam—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.00035	0.000864	CcSEcCtD
Alprazolam—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.00035	0.000864	CcSEcCtD
Alprazolam—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000343	0.000846	CcSEcCtD
Alprazolam—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000342	0.000844	CcSEcCtD
Alprazolam—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000337	0.00385	CbGpPWpGaD
Alprazolam—GABRA1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000337	0.00385	CbGpPWpGaD
Alprazolam—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000336	0.000831	CcSEcCtD
Alprazolam—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000336	0.000831	CcSEcCtD
Alprazolam—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000333	0.000824	CcSEcCtD
Alprazolam—Rash—Formoterol—chronic obstructive pulmonary disease	0.000333	0.000824	CcSEcCtD
Alprazolam—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000333	0.000823	CcSEcCtD
Alprazolam—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000333	0.000823	CcSEcCtD
Alprazolam—Weight increased—Prednisone—chronic obstructive pulmonary disease	0.000333	0.000823	CcSEcCtD
Alprazolam—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000331	0.000819	CcSEcCtD
Alprazolam—Headache—Formoterol—chronic obstructive pulmonary disease	0.000331	0.000819	CcSEcCtD
Alprazolam—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.000331	0.000818	CcSEcCtD
Alprazolam—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000331	0.000817	CcSEcCtD
Alprazolam—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.00033	0.000816	CcSEcCtD
Alprazolam—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000329	0.000814	CcSEcCtD
Alprazolam—GABRA1—SIDS Susceptibility Pathways—IL13—chronic obstructive pulmonary disease	0.000327	0.00374	CbGpPWpGaD
Alprazolam—Rash—Montelukast—chronic obstructive pulmonary disease	0.000327	0.000807	CcSEcCtD
Alprazolam—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000326	0.000806	CcSEcCtD
Alprazolam—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000326	0.000805	CcSEcCtD
Alprazolam—GABRA1—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000325	0.00372	CbGpPWpGaD
Alprazolam—Depression—Prednisone—chronic obstructive pulmonary disease	0.000325	0.000804	CcSEcCtD
Alprazolam—Headache—Montelukast—chronic obstructive pulmonary disease	0.000325	0.000802	CcSEcCtD
Alprazolam—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000321	0.000792	CcSEcCtD
Alprazolam—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000318	0.000785	CcSEcCtD
Alprazolam—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000316	0.000782	CcSEcCtD
Alprazolam—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000315	0.000779	CcSEcCtD
Alprazolam—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000315	0.000778	CcSEcCtD
Alprazolam—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000315	0.000778	CcSEcCtD
Alprazolam—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000315	0.000777	CcSEcCtD
Alprazolam—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000314	0.000776	CcSEcCtD
Alprazolam—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000314	0.000776	CcSEcCtD
Alprazolam—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000313	0.000773	CcSEcCtD
Alprazolam—Clonazepam—ALB—chronic obstructive pulmonary disease	0.000313	0.142	CrCbGaD
Alprazolam—GABRB2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000312	0.00356	CbGpPWpGaD
Alprazolam—CYP2C9—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000311	0.00355	CbGpPWpGaD
Alprazolam—CYP3A7—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.00031	0.00355	CbGpPWpGaD
Alprazolam—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.00031	0.00354	CbGpPWpGaD
Alprazolam—CYP3A5—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000309	0.00353	CbGpPWpGaD
Alprazolam—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000308	0.000762	CcSEcCtD
Alprazolam—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000308	0.00076	CcSEcCtD
Alprazolam—GABRA1—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000306	0.0035	CbGpPWpGaD
Alprazolam—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000304	0.000751	CcSEcCtD
Alprazolam—GABRA5—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000303	0.00346	CbGpPWpGaD
Alprazolam—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000298	0.00341	CbGpPWpGaD
Alprazolam—GABRA3—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000298	0.0034	CbGpPWpGaD
Alprazolam—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000297	0.000733	CcSEcCtD
Alprazolam—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000295	0.000729	CcSEcCtD
Alprazolam—GABRA1—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	0.000295	0.00337	CbGpPWpGaD
Alprazolam—GABRA2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000292	0.00334	CbGpPWpGaD
Alprazolam—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.000291	0.00072	CcSEcCtD
Alprazolam—GABRB3—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.00029	0.00332	CbGpPWpGaD
Alprazolam—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000288	0.000711	CcSEcCtD
Alprazolam—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000286	0.000708	CcSEcCtD
Alprazolam—GABRG2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000285	0.00326	CbGpPWpGaD
Alprazolam—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000282	0.000696	CcSEcCtD
Alprazolam—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.00028	0.000691	CcSEcCtD
Alprazolam—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000279	0.00319	CbGpPWpGaD
Alprazolam—Diazepam—CYP1A2—chronic obstructive pulmonary disease	0.000277	0.126	CrCbGaD
Alprazolam—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000277	0.000684	CcSEcCtD
Alprazolam—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000277	0.00316	CbGpPWpGaD
Alprazolam—Loxapine—HTR2A—chronic obstructive pulmonary disease	0.000275	0.125	CrCbGaD
Alprazolam—CYP2C9—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000275	0.00314	CbGpPWpGaD
Alprazolam—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000274	0.000676	CcSEcCtD
Alprazolam—CYP3A5—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000273	0.00312	CbGpPWpGaD
Alprazolam—CYP3A7—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000273	0.00312	CbGpPWpGaD
Alprazolam—CYP3A7—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.00027	0.00308	CbGpPWpGaD
Alprazolam—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000269	0.00307	CbGpPWpGaD
Alprazolam—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000266	0.000657	CcSEcCtD
Alprazolam—CYP2C9—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000265	0.00303	CbGpPWpGaD
Alprazolam—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000259	0.00064	CcSEcCtD
Alprazolam—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000257	0.000635	CcSEcCtD
Alprazolam—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000257	0.000634	CcSEcCtD
Alprazolam—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000255	0.00063	CcSEcCtD
Alprazolam—GABRA1—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000249	0.00285	CbGpPWpGaD
Alprazolam—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.00024	0.000594	CcSEcCtD
Alprazolam—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000237	0.000585	CcSEcCtD
Alprazolam—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000236	0.000583	CcSEcCtD
Alprazolam—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000234	0.000579	CcSEcCtD
Alprazolam—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000233	0.000576	CcSEcCtD
Alprazolam—Malaise—Prednisone—chronic obstructive pulmonary disease	0.00023	0.000568	CcSEcCtD
Alprazolam—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000229	0.000566	CcSEcCtD
Alprazolam—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000229	0.000565	CcSEcCtD
Alprazolam—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000228	0.000562	CcSEcCtD
Alprazolam—CYP3A7—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000227	0.00259	CbGpPWpGaD
Alprazolam—CYP2C9—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000226	0.00258	CbGpPWpGaD
Alprazolam—CYP3A5—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000224	0.00256	CbGpPWpGaD
Alprazolam—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000224	0.000554	CcSEcCtD
Alprazolam—CYP3A7—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000224	0.00256	CbGpPWpGaD
Alprazolam—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000221	0.000546	CcSEcCtD
Alprazolam—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000219	0.0025	CbGpPWpGaD
Alprazolam—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000218	0.00249	CbGpPWpGaD
Alprazolam—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000217	0.000536	CcSEcCtD
Alprazolam—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000217	0.000536	CcSEcCtD
Alprazolam—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000216	0.000535	CcSEcCtD
Alprazolam—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000216	0.000533	CcSEcCtD
Alprazolam—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000215	0.00053	CcSEcCtD
Alprazolam—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000211	0.000521	CcSEcCtD
Alprazolam—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000208	0.000514	CcSEcCtD
Alprazolam—Infection—Prednisone—chronic obstructive pulmonary disease	0.000207	0.000511	CcSEcCtD
Alprazolam—Shock—Prednisone—chronic obstructive pulmonary disease	0.000205	0.000506	CcSEcCtD
Alprazolam—GABRA1—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	0.000205	0.00234	CbGpPWpGaD
Alprazolam—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000204	0.000504	CcSEcCtD
Alprazolam—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000203	0.000502	CcSEcCtD
Alprazolam—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000202	0.0005	CcSEcCtD
Alprazolam—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000201	0.000497	CcSEcCtD
Alprazolam—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000198	0.00049	CcSEcCtD
Alprazolam—CYP3A5—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000197	0.00226	CbGpPWpGaD
Alprazolam—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000195	0.00223	CbGpPWpGaD
Alprazolam—CYP3A5—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000195	0.00223	CbGpPWpGaD
Alprazolam—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000193	0.0022	CbGpPWpGaD
Alprazolam—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.00019	0.000469	CcSEcCtD
Alprazolam—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000189	0.000468	CcSEcCtD
Alprazolam—CYP3A7—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000189	0.00216	CbGpPWpGaD
Alprazolam—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000188	0.000465	CcSEcCtD
Alprazolam—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000187	0.000462	CcSEcCtD
Alprazolam—CYP3A7—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000187	0.00213	CbGpPWpGaD
Alprazolam—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000183	0.000453	CcSEcCtD
Alprazolam—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000181	0.00207	CbGpPWpGaD
Alprazolam—GABRA1—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	0.000181	0.00207	CbGpPWpGaD
Alprazolam—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000181	0.000447	CcSEcCtD
Alprazolam—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000181	0.000446	CcSEcCtD
Alprazolam—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.00018	0.000446	CcSEcCtD
Alprazolam—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000179	0.000443	CcSEcCtD
Alprazolam—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000179	0.000443	CcSEcCtD
Alprazolam—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000178	0.00044	CcSEcCtD
Alprazolam—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000177	0.00202	CbGpPWpGaD
Alprazolam—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000175	0.002	CbGpPWpGaD
Alprazolam—CYP3A7—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000174	0.00199	CbGpPWpGaD
Alprazolam—CYP3A7—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000172	0.00196	CbGpPWpGaD
Alprazolam—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000172	0.000424	CcSEcCtD
Alprazolam—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.00017	0.000421	CcSEcCtD
Alprazolam—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.00017	0.00042	CcSEcCtD
Alprazolam—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000165	0.000409	CcSEcCtD
Alprazolam—CYP3A7—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000165	0.00188	CbGpPWpGaD
Alprazolam—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000165	0.000407	CcSEcCtD
Alprazolam—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000165	0.000407	CcSEcCtD
Alprazolam—CYP3A5—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000164	0.00187	CbGpPWpGaD
Alprazolam—CYP3A7—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000163	0.00186	CbGpPWpGaD
Alprazolam—CYP3A5—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000162	0.00185	CbGpPWpGaD
Alprazolam—Diazepam—ALB—chronic obstructive pulmonary disease	0.00016	0.0726	CrCbGaD
Alprazolam—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000159	0.00182	CbGpPWpGaD
Alprazolam—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000158	0.00181	CbGpPWpGaD
Alprazolam—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000153	0.000379	CcSEcCtD
Alprazolam—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000149	0.000369	CcSEcCtD
Alprazolam—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000147	0.000364	CcSEcCtD
Alprazolam—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000144	0.00164	CbGpPWpGaD
Alprazolam—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000142	0.000352	CcSEcCtD
Alprazolam—CYP2C9—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000139	0.00159	CbGpPWpGaD
Alprazolam—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000138	0.00034	CcSEcCtD
Alprazolam—CYP2C9—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000138	0.00157	CbGpPWpGaD
Alprazolam—CYP3A5—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000137	0.00156	CbGpPWpGaD
Alprazolam—CYP3A5—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000135	0.00154	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—APIP—chronic obstructive pulmonary disease	0.000133	0.00152	CbGpPWpGaD
Alprazolam—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000132	0.000327	CcSEcCtD
Alprazolam—Rash—Prednisone—chronic obstructive pulmonary disease	0.000131	0.000324	CcSEcCtD
Alprazolam—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000131	0.000324	CcSEcCtD
Alprazolam—Headache—Prednisone—chronic obstructive pulmonary disease	0.00013	0.000322	CcSEcCtD
Alprazolam—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000129	0.00147	CbGpPWpGaD
Alprazolam—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000127	0.00145	CbGpPWpGaD
Alprazolam—CYP3A5—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000126	0.00144	CbGpPWpGaD
Alprazolam—CYP3A5—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000124	0.00142	CbGpPWpGaD
Alprazolam—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000124	0.000305	CcSEcCtD
Alprazolam—CYP3A5—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000119	0.00136	CbGpPWpGaD
Alprazolam—CYP3A5—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000118	0.00134	CbGpPWpGaD
Alprazolam—CYP2C9—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000116	0.00132	CbGpPWpGaD
Alprazolam—CYP2C9—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000114	0.0013	CbGpPWpGaD
Alprazolam—GABRA1—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	0.000112	0.00128	CbGpPWpGaD
Alprazolam—GABRA1—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	0.000107	0.00123	CbGpPWpGaD
Alprazolam—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000104	0.00119	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	9.78e-05	0.00112	CbGpPWpGaD
Alprazolam—CYP2C9—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	9.64e-05	0.0011	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—APIP—chronic obstructive pulmonary disease	9.59e-05	0.0011	CbGpPWpGaD
Alprazolam—CYP2C9—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	9.51e-05	0.00109	CbGpPWpGaD
Alprazolam—GABRB2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	9.27e-05	0.00106	CbGpPWpGaD
Alprazolam—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	9.18e-05	0.00105	CbGpPWpGaD
Alprazolam—GABRA1—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	9.08e-05	0.00104	CbGpPWpGaD
Alprazolam—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	9.07e-05	0.00104	CbGpPWpGaD
Alprazolam—GABRA5—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	9.01e-05	0.00103	CbGpPWpGaD
Alprazolam—CYP2C9—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	8.86e-05	0.00101	CbGpPWpGaD
Alprazolam—GABRA3—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	8.84e-05	0.00101	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	8.79e-05	0.001	CbGpPWpGaD
Alprazolam—CYP2C9—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	8.74e-05	0.000999	CbGpPWpGaD
Alprazolam—GABRA2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	8.69e-05	0.000993	CbGpPWpGaD
Alprazolam—GABRB3—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	8.63e-05	0.000987	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—GC—chronic obstructive pulmonary disease	8.55e-05	0.000977	CbGpPWpGaD
Alprazolam—GABRG2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	8.48e-05	0.000969	CbGpPWpGaD
Alprazolam—CYP2C9—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	8.4e-05	0.00096	CbGpPWpGaD
Alprazolam—CYP2C9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	8.29e-05	0.000947	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	7.95e-05	0.000908	CbGpPWpGaD
Alprazolam—GABRA1—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	7.78e-05	0.00089	CbGpPWpGaD
Alprazolam—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	7.63e-05	0.000872	CbGpPWpGaD
Alprazolam—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	7.52e-05	0.00086	CbGpPWpGaD
Alprazolam—GABRA1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	7.41e-05	0.000847	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	6.76e-05	0.000773	CbGpPWpGaD
Alprazolam—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	6.36e-05	0.000727	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	6.35e-05	0.000726	CbGpPWpGaD
Alprazolam—GABRA1—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	6.28e-05	0.000718	CbGpPWpGaD
Alprazolam—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	6.27e-05	0.000717	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—GC—chronic obstructive pulmonary disease	6.18e-05	0.000706	CbGpPWpGaD
Alprazolam—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	5.84e-05	0.000668	CbGpPWpGaD
Alprazolam—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	5.76e-05	0.000659	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	5.74e-05	0.000657	CbGpPWpGaD
Alprazolam—GABRB2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	5.57e-05	0.000636	CbGpPWpGaD
Alprazolam—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	5.54e-05	0.000633	CbGpPWpGaD
Alprazolam—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	5.46e-05	0.000625	CbGpPWpGaD
Alprazolam—GABRA5—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	5.41e-05	0.000618	CbGpPWpGaD
Alprazolam—GABRA3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	5.31e-05	0.000607	CbGpPWpGaD
Alprazolam—GABRA2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	5.22e-05	0.000596	CbGpPWpGaD
Alprazolam—GABRB3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	5.18e-05	0.000593	CbGpPWpGaD
Alprazolam—GABRG2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	5.09e-05	0.000582	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	4.82e-05	0.000551	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.67e-05	0.000534	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—GCLC—chronic obstructive pulmonary disease	4.62e-05	0.000528	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.48e-05	0.000512	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	4.46e-05	0.000509	CbGpPWpGaD
Alprazolam—GABRA1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	4.45e-05	0.000509	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	4.44e-05	0.000507	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	4.36e-05	0.000498	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—CTGF—chronic obstructive pulmonary disease	4.21e-05	0.000481	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.05e-05	0.000463	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.88e-05	0.000444	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.38e-05	0.000386	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—GCLC—chronic obstructive pulmonary disease	3.34e-05	0.000381	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.24e-05	0.00037	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	3.23e-05	0.000369	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.19e-05	0.000365	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—CTGF—chronic obstructive pulmonary disease	3.04e-05	0.000348	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.97e-05	0.00034	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.95e-05	0.000337	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	2.87e-05	0.000328	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.82e-05	0.000322	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.81e-05	0.000321	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.67e-05	0.000305	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.38e-05	0.000272	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	2.35e-05	0.000269	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.34e-05	0.000267	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.31e-05	0.000264	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.19e-05	0.000251	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.15e-05	0.000246	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	2.15e-05	0.000245	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.04e-05	0.000233	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.98e-05	0.000226	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—ALB—chronic obstructive pulmonary disease	1.92e-05	0.000219	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—NOS3—chronic obstructive pulmonary disease	1.83e-05	0.00021	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.65e-05	0.000189	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.63e-05	0.000186	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.57e-05	0.000179	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	1.55e-05	0.000177	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.52e-05	0.000173	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.44e-05	0.000164	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	1.42e-05	0.000162	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—ALB—chronic obstructive pulmonary disease	1.39e-05	0.000158	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—NOS3—chronic obstructive pulmonary disease	1.33e-05	0.000151	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.3e-05	0.000149	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.09e-05	0.000124	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.07e-05	0.000123	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	1e-05	0.000114	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	9.77e-06	0.000112	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.48e-06	0.000108	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	9.34e-06	0.000107	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	6.44e-06	7.36e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	6.16e-06	7.04e-05	CbGpPWpGaD
